DT-optimum designs for model discrimination and parameter estimation, Journal of Statistical Planning and Inference, vol.138, issue.1, pp.56-64, 2008. ,
DOI : 10.1016/j.jspi.2007.05.024
Optimum Experimental Designs with SAS, 2009. ,
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model, Statistics in Medicine, vol.28, issue.14, pp.1940-1956, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00371363
MCPMod: An R package for the design and analysis of dose-finding studies, Journal of Statistical Software, vol.29, issue.7, pp.1-23, 2009. ,
Comparison of model averaging and model selection in dose finding trials analyzed by nonlinear mixed effect models, The AAPS Journal, vol.20, issue.3, p.56, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01807517
Minimax optimal designs via particle swarm optimization methods, Statistics and Computing, vol.25, issue.5, pp.975-988, 2015. ,
DOI : 10.1007/s11222-014-9466-0
Two-stage adaptive designs in nonlinear mixed effects models: application to pharmacokinetics in children, Communications in Statistics-Simulation and Computation, vol.45, issue.5, pp.1511-1525, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01076940
PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models, Computer Methods and Programs in Biomedicine, vol.156, pp.217-229, 2018. ,
DOI : 10.1016/j.cmpb.2018.01.008
URL : https://hal.archives-ouvertes.fr/inserm-01698017
Optimal design for nonlinear response models, 2013. ,
DOI : 10.1201/b15054
Methods of robust design of nonlinear models with an application to pharmacokinetics, Journal of Biopharmaceutical Statistics, vol.20, issue.4, pp.886-902, 2010. ,
Comparison of robust criteria for D-optimal designs, Journal of Biopharmaceutical Statistics, vol.22, issue.6, pp.1193-1205, 2012. ,
Fast computation of designs robust to parameter uncertainty for nonlinear settings, Technometrics, vol.51, issue.1, 2009. ,
Design of cross-over trials for pharmacokinetic studies, Journal of Statistical Planning and Inference, vol.78, issue.1-2, pp.307-316, 1999. ,
General equivalence theory for optimum designs (approximate theory). The Annals of Statistics, pp.849-879, 1974. ,
A novel global search algorithm for nonlinear mixed-effects models using particle swarm optimization, Journal of Pharmacokinetics and Pharmacodynamics, vol.38, issue.4, pp.471-495, 2011. ,
Influence of the size of cohorts in adaptive design for nonlinear mixed effects models: an evaluation by simulation for a pharmacokinetic and pharmacodynamic model for a biomarker in oncology, Pharmaceutical Research, vol.32, issue.10, pp.3159-3169, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01179444
Robust design in model-based analysis of longitudinal clinical data, Number Abstr, vol.5, 2016. ,
D optimal designs for three poisson dose-response models, Journal of Pharmacokinetics and Pharmacodynamics, vol.40, issue.2, pp.201-211, 2013. ,
Improved near-exact distributions for the product of independent generalized gamma random variables, Computational Statistics & Data Analysis, vol.102, pp.55-66, 2016. ,
Optimal design in random-effects regression models, Biometrika, vol.84, issue.2, pp.429-442, 1997. ,
Basic concepts in population modeling, simulation, and model-based drug development, CPT: Pharmacometrics & Systems Pharmacology, vol.1, issue.9, pp.1-14, 2012. ,
Basic concepts in population modeling, simulation, and modelbased drug development: Part 2: Introduction to pharmacokinetic modeling methods, CPT: Pharmacometrics & Systems Pharmacology, vol.2, issue.4, pp.1-14, 2013. ,
Design optimisation for pharmacokinetic modeling of a cocktail of phenotyping drugs, Pharmaceutical Statistics, vol.15, issue.2, pp.165-177, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01869138
Evaluation of the Fisher information matrix in nonlinear mixed effect models using adaptive Gaussian quadrature, Computational Statistics & Data Analysis, vol.80, issue.0, pp.57-69, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01077176
Population optimal experimental design for discrete type data. PAGE 18 , Number Abstr 1468, 2009. ,
Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments, Journal of Pharmacokinetics and Pharmacodynamics, vol.38, issue.4, pp.449-469, 2011. ,
Quasi-Monte Carlo estimation in generalized linear mixed models, Computational Statistics & Data Analysis, vol.51, issue.12, pp.5765-5775, 2007. ,
Model-based dose finding under model uncertainty using general parametric models, Statistics in Medicine, vol.33, issue.10, pp.1646-1661, 2014. ,
Design of experiments in nonlinear models, Lecture Notes in Statistics, vol.212, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00879984
Robust experiment design via stochastic approximation, Mathematical Biosciences, vol.75, issue.1, pp.103-120, 1985. ,
Design optimization in nonlinear mixed effects models using cost functions: application to a joint model of infliximab and methotrexate pharmacokinetics, Communications in Statistics -Theory and Methods, vol.38, issue.18, pp.3351-3368, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00424247
, , 2015.
An MCMC method for the evaluation of the Fisher information matrix for non-linear mixed effect models, Biostatistics, vol.17, issue.4, pp.737-750, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01323747
D-optimal designs for poisson regression models, Statistica Sinica, pp.721-730, 2009. ,
RStan: the R interface to stan, 2016. ,
Computation of the Fisher information matrix for discrete nonlinear mixed effect models, Number Abstr EO0936, 2015. ,
A new method for evaluation of the Fisher information matrix for discrete mixed effect models using Monte Carlo sampling and adaptive Gaussian quadrature, methods. CPT: Pharmacometrics & Systems Pharmacology, vol.111, issue.1, pp.1-16, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01397584
Optimal experiment design for nonlinear models subject to large prior uncertainties, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol.253, issue.3, pp.530-534, 1987. ,
From cell survival to dose response: modeling biological effects in radiation therapy, 2013. ,